ANI Pharmaceuticals ANIP Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's accounts payable?
- ANI Pharmaceuticals (ANIP) reported accounts payable of $69.69M in Q1 2026.
- How has ANI Pharmaceuticals's accounts payable changed year-over-year?
- ANI Pharmaceuticals's accounts payable increased by 31.4% year-over-year, from $53.06M to $69.69M.
- What is the long-term trend for ANI Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's accounts payable has grown at a 40.9% compound annual growth rate (CAGR), from $11.26M to $62.58M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.